Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have documented evidence of reduced blood flow to the heart muscle (confirm with trial site)
- People who have at least one coronary artery with moderate to severe calcium buildup, confirmed by imaging, with a significant narrowing of the artery that is suitable for a procedure to open the artery
- People whose blocked artery can be crossed with a thin guidewire used during heart procedures
- People aged 18 years or older
- People who are willing and able to follow the study procedures and attend follow-up appointments
Who may not be able to join:
- People who are in cardiogenic shock (when the heart suddenly cannot pump enough blood to meet the body's needs)
- People who are having a certain type of serious heart attack called an ST-segment elevation myocardial infarction
- People who have a narrowing inside a previously placed stent
- People who have had a blood clot form inside a stent
- People who have a tear in a coronary artery wall
- People who have a completely blocked major coronary artery
- People whose heart pumping function is significantly reduced (below 30%)
- People who need open-heart bypass surgery
- People with a documented allergy to everolimus or to any stent material
- People who cannot take two blood-thinning medications together for at least 3 months (unless they are already on a blood-thinning tablet taken by mouth)
- People who are pregnant, breastfeeding, or planning to become pregnant within one year
- People with a life expectancy of less than one year
- People who are already taking part in another clinical trial involving an investigational treatment
- People who are unable to give informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robert A Byrne, RCSI University of Medicine and Health Sciences
Phone: 00353858802094
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Minimum stent area (MSA); Target lesion failure (TLF)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.